CN118574619A - 吉泊达星和万古霉素用于治疗由腐生葡萄球菌引起的感染 - Google Patents
吉泊达星和万古霉素用于治疗由腐生葡萄球菌引起的感染 Download PDFInfo
- Publication number
- CN118574619A CN118574619A CN202380017824.7A CN202380017824A CN118574619A CN 118574619 A CN118574619 A CN 118574619A CN 202380017824 A CN202380017824 A CN 202380017824A CN 118574619 A CN118574619 A CN 118574619A
- Authority
- CN
- China
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- vancomycin
- staphylococcus saprophyticus
- gemfibrozil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263301522P | 2022-01-21 | 2022-01-21 | |
| US63/301,522 | 2022-01-21 | ||
| PCT/EP2023/051177 WO2023139147A1 (en) | 2022-01-21 | 2023-01-19 | Gepotidacin and vancomycin for use in the treatment of an infection caused by staphylococcus saprophyticus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN118574619A true CN118574619A (zh) | 2024-08-30 |
Family
ID=85108785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202380017824.7A Pending CN118574619A (zh) | 2022-01-21 | 2023-01-19 | 吉泊达星和万古霉素用于治疗由腐生葡萄球菌引起的感染 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250099535A1 (https=) |
| EP (1) | EP4465989A1 (https=) |
| JP (1) | JP2025502442A (https=) |
| CN (1) | CN118574619A (https=) |
| CA (1) | CA3240991A1 (https=) |
| WO (1) | WO2023139147A1 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008240764C1 (en) | 2007-04-20 | 2011-10-20 | Glaxo Group Limited | Tricyclic nitrogen containing compounds as antibacterial agents |
| EP3946342A1 (en) * | 2019-04-03 | 2022-02-09 | GlaxoSmithKline Intellectual Property Development Limited | Gepotidacin for use in the treatment of bacterial urinary tract infections |
-
2023
- 2023-01-19 JP JP2024543244A patent/JP2025502442A/ja active Pending
- 2023-01-19 CA CA3240991A patent/CA3240991A1/en active Pending
- 2023-01-19 CN CN202380017824.7A patent/CN118574619A/zh active Pending
- 2023-01-19 EP EP23702056.5A patent/EP4465989A1/en active Pending
- 2023-01-19 US US18/728,991 patent/US20250099535A1/en active Pending
- 2023-01-19 WO PCT/EP2023/051177 patent/WO2023139147A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023139147A1 (en) | 2023-07-27 |
| CA3240991A1 (en) | 2023-07-27 |
| EP4465989A1 (en) | 2024-11-27 |
| JP2025502442A (ja) | 2025-01-24 |
| US20250099535A1 (en) | 2025-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8153166B2 (en) | Composition for prophylaxis or treatment of urinary system infection and method thereof | |
| Mikuniya et al. | Treatment of Pseudomonas aeruginosa biofilms with a combination of fluoroquinolones and fosfomycin in a rat urinary tract infection model | |
| US9034918B2 (en) | Composition including at least one trans-cinnamaldehyde and the use thereof in the treatment of bacterial infections, specifically in the treatment of nosocomial infections | |
| Nicolle et al. | Prospective, randomized, placebo-controlled trial of norfloxacin for the prophylaxis of recurrent urinary tract infection in women | |
| US20020086867A1 (en) | Methods of use of quinolone compounds against atypical upper respiratory pathogenic bacteria | |
| JP2010174032A (ja) | 微生物の院内感染症の治療用医薬の製造におけるタウロリジンまたはタウラルタムのような抗微生物薬剤の使用 | |
| KR20200026118A (ko) | 헬리코박터 파일로리 제균용 조성물 | |
| CN114828854A (zh) | 用于治疗细菌性尿路感染的吉泊达星 | |
| JP2022539583A (ja) | マイコプラズマ・ジェニタリウムによって引き起こされる感染症の治療のための組合せ | |
| Raz et al. | Intravenous administration of gentamicin once daily versus thrice daily in adults | |
| CN116350628B (zh) | Su3327在制备降低多黏菌素细胞毒性和肾毒性的药物中的用途 | |
| JP2002500189A5 (https=) | ||
| CN118574619A (zh) | 吉泊达星和万古霉素用于治疗由腐生葡萄球菌引起的感染 | |
| CN101543506A (zh) | 预防或治疗猪链球菌病的复方抗生素组合物 | |
| López-Brea et al. | Study of the combination of ranitidine bismuth citrate and metronidazole against metronidazole-resistant Helicobacter pylori clinical isolates. | |
| BRPI0918593B1 (pt) | composição farmacêutica para uso no tratamento de infecções sexualmente transmitidas | |
| US7595328B2 (en) | Methods of use of quinolone compounds against pneumococcal and Haemophilus bacteria | |
| KR20250012088A (ko) | 항생제 조합 요법 | |
| CA2468033C (en) | A method of treating bacterial infections using gemifloxacin or a salt thereof and a carbapenem antibacterial agent | |
| PT1458391E (pt) | Um processo para tratamento de infecções bacterianas através do uso de gemifloxacina ou um seu sal e um antibiótico b-lactâmico | |
| CN109045044A (zh) | 一种复方药剂及其制备方法、用途 | |
| US20040023983A1 (en) | Methods of use of fluoroquinolone compounds against pathogenic helicobacter bacteria | |
| Weigelt et al. | Use of quinolones in surgery and obstetrics and gynecology | |
| CN114366730A (zh) | 没食子酸及包含其的药物组合物用于治疗细菌性前列腺炎的应用 | |
| KR20030060928A (ko) | 병원성 헬리코박터 박테리아에 대한 플루오로퀴놀론화합물의 사용방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |